Biotech Boom or Biotech Bubble?

January 20, 2015 | "I have my seatbelt and crash helmet on," a biotech CEO tells The New York Times in an investigation of soaring biotechnology stocks and drug approvals in the wake of last week's J.P. Morgan Healthcare Conference. With the disastrous early-2000's bubble still fresh in many executives' minds, excitement about the industry's recent fortunes is mingled with anxiety about how much drug developers still don't understand about human biology. New York Times